Identification of SGK1 as a potential therapeutic target in castrate resistance prostate cancer

被引：0
|
作者：
Alsamraae, Massar I.
McClurg, Urzsula
Robson, Craig N.
McCracken, Stuart
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SGK1 in Cancer: Biomarker and Drug Target
    Cicenas, Jonas
    Meskinyte-Kausiliene, Edita
    Jukna, Vigilijus
    Rimkus, Arnas
    Simkus, Jokubas
    Soderholm, Diana
    CANCERS, 2022, 14 (10)
  • [2] SGK1 IS A PROGNOSTIC MARKER AND NOVEL THERAPEUTIC TARGET IN MEDULLOBLASTOMA
    Sturm, D.
    Pleier, S.
    Remke, M.
    Witt, H.
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A. E.
    Witt, O.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II56 - II57
  • [3] Therapeutic inhibition of SGK1 suppresses colorectal cancer
    Liang, Xuchun
    Lan, Chunling
    Jiao, Guanming
    Fu, Wencheng
    Long, Xuesha
    An, Yu
    Wang, Kejin
    Zhou, Jinzhe
    Chen, Ting
    Li, Yongqin
    Xu, Jiahong
    Huang, Qi
    Xu, Bin
    Xiao, Junjie
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e399 - e399
  • [4] Therapeutic inhibition of SGK1 suppresses colorectal cancer
    Xuchun Liang
    Chunling Lan
    Guanming Jiao
    Wencheng Fu
    Xuesha Long
    Yu An
    Kejin Wang
    Jinzhe Zhou
    Ting Chen
    Yongqin Li
    Jiahong Xu
    Qi Huang
    Bin Xu
    Junjie Xiao
    Experimental & Molecular Medicine, 2017, 49 : e399 - e399
  • [5] SGK1: a novel prognostic marker and potential drug target in medulloblastoma
    Pleier, S.
    Sturm, D.
    Remke, M.
    Witt, H.
    Goidts, V
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A. E.
    Korshunov, A.
    Lichter, P.
    Pfister, S. M.
    KLINISCHE PADIATRIE, 2011, 223 (03): : 197 - 198
  • [6] SGK1, autophagy and cancer: an overview
    Madiha Javeed Ghani
    Molecular Biology Reports, 2022, 49 : 675 - 685
  • [7] Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
    Lin, Dong
    Dong, Xin
    Wang, Kendric
    Wyatt, Alexander W.
    Crea, Francesco
    Xue, Hui
    Wang, Yuwei
    Wu, Rebecca
    Bell, Robert H.
    Haegert, Anne
    Brahmbhatt, Sonal
    Hurtado-Coll, Antonio
    Gout, Peter W.
    Fazli, Ladan
    Gleave, Martin E.
    Collins, Colin C.
    Wang, Yuzhuo
    ONCOTARGET, 2015, 6 (03) : 1806 - 1820
  • [8] WNT/β-CATENIN SIGNALLING IS A POTENTIAL THERAPEUTIC TARGET FOR CASTRATE-RESISTANT PROSTATE CANCER.
    Kawano, Yoshiaki
    Maeda, Yoshihiro
    Motoshima, Takanobu
    Imamura, Takahisa
    Takahashi, Wataru
    Wada, Yoshihiro
    Kypta, Robert
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E504 - E505
  • [9] SGK1, autophagy and cancer: an overview
    Ghani, Madiha Javeed
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (01) : 675 - 685
  • [10] Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents
    Maestro, Ines
    Madruga, Enrique
    Boya, Patricia
    Martinez, Ana
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
12345